TLR4 interactor with leucine rich repeats
protein-coding gene in the species Homo sapiens
TLR4 interactor with leucine rich repeats, also known as KIAA0644, is a protein that in humans is encoded by the TRIL gene.
Function
The exact function of KIAA0644 is not known. It is, however, a member of the leucine-rich repeat family of proteins, which are known to be involved in protein-protein interactions. This protein is known to interact with the TLR4 protein.
TRIL is a component of the TLR4 complex and is induced in a number of cell types by lipopolysaccharide (LPS).
Protein sequence
The main isoform of the human protein is 811 amino long and is composed primarily of leucine (17%), alanine and arginine (~10%), and glycine (~ 8.5%) residues. The protein sequence is predicted to consists mostly of α-helices and a few β-sheet
Homology
KIAA0644 is conserved well among mammals but can be found in all chordates with lower sequence identities.
Gene neighborhood
The KIAA0644 gene is neighbors to mRNA-cAMP responsive element binding gene downstream and mRNA carboxypeptidase and serine carboxypeptidase gene upstream
References
Further reading
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
This brief starts where responsible research should: with the source description of “TLR4 interactor with leucine rich repeats” as protein-coding gene in the species Homo sapiens. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the science & nature register because the source frames it as protein-coding gene in the species Homo sapiens. Its deeper value depends on whether names, dates, institutions and citations support that framing.
Stable identifiers, scientific names and standards terminology offer the best bridge between this overview and specialist evidence. The source revision retrieved here is dated Jul 4, 2026. The linked authority identifier is Q18034741. None of the 0 selected statements returned an explicit reference.
Current terminology should not be projected backward without checking the classification used when the underlying evidence was created. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.
- Current terminology
- Classification context
- Finding cited technical literature
Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.
Three-step research path
- Establish the record: confirm the title “TLR4 interactor with leucine rich repeats”, its source revision and the description used here.
- Expand the search: follow TLR4 interactor with leucine rich repeats primary sources, TLR4 interactor with leucine rich repeats archive and TLR4 research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “TLR4 interactor with leucine rich repeats”?
- Which observation, specimen, dataset or publication supports the account?
- Is the terminology current, historical or disputed?
Search terms from this dossier
This entry incorporates text from “TLR4 interactor with leucine rich repeats” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.